BioSpace News Archive

Check out this article for the impacts that Biotech Bay companies are experiencing due to COVID-19.

AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced new long-term results showing that once daily upadacitinib continued to improve signs and symptoms in patients with rheumatoid arthritis at 72 and 84 weeks in the SELECT-COMPARE (upadacitinib, 15 mg in combination with methotrexate [MTX]) and SELECT-MONOTHERAPY

At the 2020 American Society of Clinical Oncology (ASCO) Virtual Annual Meeting, Noxopharm , a clinical-stage Australian oncology drug development company, has reported two sets of clinical data relating to the development of NOX66 ( Veyonda ® ) as a treatment for end-stage cancer. The posters addressed how NOX66 may improve treatment responses in men with mCRPC and also its contribution to restoring sensitivity to apop

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it has successfully executed a binding funding agreement with leading institutional investors to raise $200 million a

- adMare BioInnovations, Canada’s Global Life Sciences Venture, along with partners McGill University and AmorChem II Fund l.p., a leading early-stage venture capital fund, is advancing made-in- Canada research that aims to provide new opiate-sparing pain-relieving drugs. adMare and AmorChem have created a new company, Neurasic Therapeuti

Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced that the results from Study 209, a Phase 2b study of the investigational agent HTX-011 in primary uni

ROSEMONT, PA, June 4, 2020 /PRNewswire/ - Duchesnay USA, a pharmaceutical company that specializes in women’s health, is proud to announce the launch of a new video titled Straight Talk: Sex and the Menopausal Woman.

Weekly prizes aim to reduce migraine days for patients and culminate in a grand prize of the FDA-cleared medical device to mark National Migraine and Headache Awareness Month this June [04-June-2020] NEW YORK , June 4, 2020 /PRNewswire/ -- CEFALY , the first device of its kind to receive FDA medical clearance for migraine headaches, is launching a nationwide giveaway

Scality, a leader in software solutions for global data orchestration and distributed file and object storage today reported how the Scality RING brings unique efficiencies in today’s modern healthcare and genomic data centers.

John Wiley & Sons Inc. and the American Association for the Advancement of Science announced their collaboration to strengthen and support the Science Careers job board.